{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:00:43Z","timestamp":1773298843004,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.amjmed.2009.01.016","type":"journal-article","created":{"date-parts":[[2009,5,30]],"date-time":"2009-05-30T04:23:46Z","timestamp":1243657426000},"page":"497-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Helping Women Choose Appropriate Hormonal Contraception: Update on Risks, Benefits, and Indications"],"prefix":"10.1016","volume":"122","author":[{"given":"Abby L.","family":"Spencer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Bonnema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan C.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.amjmed.2009.01.016_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1363\/3809006","article-title":"Disparities in rates of unintended pregnancy in the United States, 1994 and 2001","volume":"38","author":"Finer","year":"2006","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.amjmed.2009.01.016_bib2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-147-6-200709180-00006","article-title":"Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women","volume":"147","author":"Schwartz","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2009.01.016_bib3","series-title":"Contraceptive Technology","first-page":"747","article-title":"Contraceptive efficacy","author":"Trussell","year":"2007"},{"key":"10.1016\/j.amjmed.2009.01.016_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.contraception.2004.02.010","article-title":"Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives","volume":"70","author":"Sidney","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.amjmed.2009.01.016_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0010-7824(98)00014-6","article-title":"Newer oral contraceptives and the risk of venous thromboembolism","volume":"57","author":"Walker","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.amjmed.2009.01.016_bib6","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/00006250-200606000-00055","article-title":"ACOG practice bulletin. No. 73: use of hormonal contraception in women with coexisting medical conditions","volume":"107","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2009.01.016_bib7","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/01.STR.29.11.2277","article-title":"Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies","volume":"29","author":"Schwartz","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.amjmed.2009.01.016_bib8","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1161\/STROKEAHA.107.488395","article-title":"Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study","volume":"38","author":"MacClellan","year":"2007","journal-title":"Stroke"},{"issue":"15","key":"10.1016\/j.amjmed.2009.01.016_bib9","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMcp030751","article-title":"Combination estrogen\u2013progestin oral contraceptives","volume":"349","author":"Petitti","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.01.016_bib11","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa013202","article-title":"Oral contraceptives and the risk of breast cancer","volume":"346","author":"Marchbanks","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.amjmed.2009.01.016_bib12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/humupd\/dmi019","article-title":"Noncontraceptive health benefits of combined oral contraception","volume":"11","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.amjmed.2009.01.016_bib13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2009.01.016_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2009.01.016_bib15","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/humrep\/12.9.1851","article-title":"Risk of endometrial cancer in relation to use of combined oral contraceptives: a practitioner's guide to meta-analysis","volume":"12","author":"Schlesselman","year":"1997","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.amjmed.2009.01.016_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2006.08.004","article-title":"Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg\/ethinyl estradiol 20 \u03bcg","volume":"75","author":"Nakajima","year":"2007","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.amjmed.2009.01.016_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.contraception.2005.09.010","article-title":"Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol","volume":"73","author":"Anderson","year":"2006","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.amjmed.2009.01.016_bib18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.contraception.2006.07.005","article-title":"Evaluation of a continuous regimen of levonorgestrel\/ethinyl estradiol: phase 3 study results","volume":"74","author":"Archer","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.amjmed.2009.01.016_bib19","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1097\/00006250-200604001-00007","article-title":"Return to menses after continuous use of a low-dose oral contraceptive","volume":"107","author":"Davis","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2009.01.016_bib20","first-page":"1816","article-title":"Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism","volume":"80","author":"Oelkers","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2009.01.016_bib21","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.104.501502","article-title":"Antihypertensive effects of drospirenone with 17\u03b2-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension","volume":"112","author":"White","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2009.01.016_bib23","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ajog.2004.02.012","article-title":"Manipulation of the pill-free interval in oral contraceptive pill users: the effects on follicular suppression","volume":"190","author":"Schlaff","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2009.01.016_bib24","first-page":"261","article-title":"Hormone withdrawal symptoms in oral contraceptive users","volume":"95","author":"Sulak","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2009.01.016_bib25","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2006.05.012","article-title":"Oral contraceptives and premenstrual symptoms: comparison of a 21\/7 and extended regimen","volume":"195","author":"Coffee","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.amjmed.2009.01.016_bib26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.contraception.2007.11.005","article-title":"Evaluation of pituitary\u2013ovarian axis suppression with three oral contraceptive regimens","volume":"77","author":"Vandever","year":"2008","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.amjmed.2009.01.016_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004695.pub2","article-title":"Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception","author":"Edelman","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"2 Suppl 2","key":"10.1016\/j.amjmed.2009.01.016_bib28","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0015-0282(01)03275-7","article-title":"Contraceptive efficacy and cycle control with the Ortho Evra\u2122\/Evra transdermal system: the analysis of pooled data","volume":"77","author":"Zieman","year":"2002","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.amjmed.2009.01.016_bib30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1056\/NEJM199607113350207","article-title":"Venous thromboembolism during pregnancy","volume":"335","author":"Toglia","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.01.016_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(02)00514-0","article-title":"The combined contraceptive vaginal ring, NuvaRing\u00ae: an international study of user acceptability","volume":"67","author":"Novak","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.amjmed.2009.01.016_bib32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0010-7824(03)00136-7","article-title":"Depot-medroxyprogesterone acetate injection (Depo-Provera trademark sign): a highly effective contraceptive option with proven long-term safety","volume":"68","author":"Westhoff","year":"2003","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.amjmed.2009.01.016_bib33","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/GRF.0b013e318159c20a","article-title":"Injectable contraception","volume":"50","author":"Haider","year":"2007","journal-title":"Clin Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.amjmed.2009.01.016_bib34","article-title":"Steroid hormones for contraception in women with sickle cell disease","author":"Manchikanti","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjmed.2009.01.016_bib35","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0002-9378(12)90945-X","article-title":"Contraceptive methods for women with neurologic disorders","volume":"168","author":"Mattson","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.amjmed.2009.01.016_bib36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0010-7824(98)00041-9","article-title":"Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives: results of an international, multicenter, case-control study","volume":"57","year":"1998","journal-title":"Contraception"},{"issue":"10","key":"10.1016\/j.amjmed.2009.01.016_bib37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/jama.1995.03520340055036","article-title":"Depot medroxyprogesterone acetate and breast cancer","volume":"273","author":"Skegg","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2009.01.016_bib38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.contraception.2005.05.011","article-title":"Depo-Provera's black box: time to reconsider?","volume":"72","author":"Kaunitz","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.amjmed.2009.01.016_bib39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.contraception.2006.03.010","article-title":"Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone aceteate: recovery following discontinuation","volume":"74","author":"Kaunitz","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.amjmed.2009.01.016_bib40","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.contraception.2005.12.010","article-title":"Progestogen-only contraception and bone mineral density: a systematic review","volume":"73","author":"Curtis","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.amjmed.2009.01.016_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2007.10.005","article-title":"Bone density recovery after depot medroxyprogesterone acetate injectable contraception use","volume":"77","author":"Kaunitz","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.amjmed.2009.01.016_bib42","series-title":"WHO statement on hormonal contraception and bone health","year":"2005"},{"key":"10.1016\/j.amjmed.2009.01.016_bib43","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/GRF.0b013e318159c2f6","article-title":"The contraceptive implant","volume":"50","author":"Hohmann","year":"2007","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.amjmed.2009.01.016_bib44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/humrep\/15.1.118","article-title":"Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception","volume":"15","author":"Beerthuizen","year":"2000","journal-title":"Hum Reprod"},{"issue":"Suppl 1","key":"10.1016\/j.amjmed.2009.01.016_bib45","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/13625180801942754","article-title":"The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience","volume":"13","author":"Graesslin","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"64","key":"10.1016\/j.amjmed.2009.01.016_bib46","first-page":"101","article-title":"Choice of contraceptives","volume":"5","year":"2007","journal-title":"Treat Guidel Med Lett"},{"key":"10.1016\/j.amjmed.2009.01.016_bib47","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/humrep\/14.4.976","article-title":"A multicentre efficacy and safety study of the single contraceptive implant Implanon","volume":"14","author":"Croxatto","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.amjmed.2009.01.016_bib48","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0015-0282(98)00015-6","article-title":"Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant","volume":"69","author":"Makarainen","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.amjmed.2009.01.016_bib49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.contraception.2004.11.007","article-title":"Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel","volume":"71","author":"Funk","year":"2005","journal-title":"Contraception"},{"issue":"S1","key":"10.1016\/j.amjmed.2009.01.016_bib50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/13625180801960012","article-title":"Tolerability and clinical safety of Implanon","volume":"13","author":"Blumenthal","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.amjmed.2009.01.016_bib51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0010-7824(98)00041-9","article-title":"Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives: results of an international, multicenter, case-control study","volume":"57","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.amjmed.2009.01.016_bib52","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2004.07.009","article-title":"Progestogen-only contraception in women at high risk of venous thromboembolism","volume":"70","author":"Conard","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.amjmed.2009.01.016_bib53","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/humrep\/dem153","article-title":"Use of the etonogestrel-releasing implant is associated with hypoactivation of the coagulation cascade","volume":"22","author":"Vieria","year":"2007","journal-title":"Hum Reprod"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934309001065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934309001065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:51:00Z","timestamp":1757580660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934309001065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0002934309001065"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2009.01.016","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Helping Women Choose Appropriate Hormonal Contraception: Update on Risks, Benefits, and Indications","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2009.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}